- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04926064
Young Children's Sleep Patterns and Problems Among Turkish Children
Young Children's Sleep Patterns and Problems Among Turkish Children: Cross-sectional Study From a Nationally Representative Sample
Sleep is important for optimal child growth, development, and family functioning. Behavioral pediatric insomnia is one of the most prevalent sleep disorders identified in young children. Well-child visits represent an important setting for addressing concerns regarding the child's sleep patterns and sleep problems.
Investigators aimed to describe sleep/wake patterns of young children, evaluate the associations between parental depressive, and anxiety symptoms, parental involvement in child-care, sleep-related behaviors and children's sleep parameters.
The study has a descriptive cross-sectional study design. An estimated sample size was 2089 participants considering the number of children aged between 6-36 months in the country, and the estimated prevalence of Behavioral Insomnia being 30%. A multi-stage stratification is used to calculate the number of participants to be taken at the level of 12 geographical regions according to Nomenclature of Territorial Units for Statistics (NUTS-1). A sleep study group is established by the study coordinator, and researchers running a well-child outpatient clinic from each region across the country are included.
Investigators invite mothers of children aged 6 to 36 months who either visited for a well-child outpatient clinic or in the waiting list for follow up to complete the online questionnaire about their children's sleep/wake patterns utilizing mailing lists obtained from the outpatient clinics. Recruitment will take place from April to June 2021. The questionnaire included Brief Infant Sleep Questionnaire (BISQ), Edinburgh Postnatal Depression Scale (EPDS) and Generalized Anxiety Disorder (GAD-7) scale, and separate questions on fathers' involvement in child care, and sociodemographic characteristics. An online google survey is developed on the google platform securing data collection by a confidential log in system which can be filled out from smartphones, tablet or computer. The questionnaire takes approximately 20 minutes to complete.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Sleep is important for optimal child growth, development, and family functioning. Behavioral pediatric insomnia is one of the most prevalent sleep disorders identified in young children. Well-child visits represent an important setting for addressing concerns regarding the child's sleep patterns and sleep problems.
Investigators aimed to describe sleep/wake patterns of young children, evaluate the associations between parental depressive, and anxiety symptoms, parental involvement in child-care, sleep-related behaviors and children's sleep parameters.
The study has a descriptive cross-sectional study design. According to the formula for the known number of individuals in the universe [Sample formula with known number of individuals n = [Np(1-p)]/ [(d2/Z21-α/2*(N-1)+p*(1-p)], (α=0.05, p=0.32, d=0.02) the sample size to represent the population was found to be 2089, considering the number of children aged between 6-36 months in the country, and the estimated prevalence of Behavioral Insomnia being 30%. A multi-stage stratification is used to calculate the number of participants to be taken at the level of 12 geographical regions according to Nomenclature of Territorial Units for Statistics (NUTS-1). A sleep study group is established by the study coordinator, and researchers running a well-child outpatient clinic from each region across the country are included.
Investigators invite mothers of children aged 6 to 36 months who either visited for a well-child outpatient clinic or in the waiting list for follow up to complete the online questionnaire about their children's sleep/wake patterns utilizing mailing lists obtained from the outpatient clinics. Recruitment will take place from April to June 2021. The questionnaire included Brief Infant Sleep Questionnaire (BISQ), Edinburgh Postnatal Depression Scale (EPDS) and Generalized Anxiety Disorder (GAD-7) scale, and separate questions on fathers' involvement in child care, and sociodemographic characteristics. An online google survey is developed on the google platform securing data collection by a confidential log in system which can be filled out from smartphones, tablet or computer. The questionnaire takes approximately 20 minutes to complete.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Istanbul, Tacchino
- Marmara University School of Medicine
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- mothers of healthy infants aged between 6 to 36 months
Exclusion Criteria:
infants <37 gestational week, congenital disease, neurodevelopmental disorder, use of drugs that can affect sleep such as diphenhydramine, Obstructive Sleep Apnea diagnosis
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Sleep wake patterns
Lasso di tempo: Baseline
|
Sleep wake patterns of children aged between 6-36 months
|
Baseline
|
|
Sleep problem
Lasso di tempo: Baseline
|
Maternal report of sleep problem
|
Baseline
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
maternal depression
Lasso di tempo: Baseline
|
maternal depression score assessed with Edinburgh Postnatal Depression Scale
|
Baseline
|
|
maternal anxiety
Lasso di tempo: baseline
|
maternal anxiety score assessed with Generalized Anxiety Scale-7
|
baseline
|
|
paternal involvement in child care
Lasso di tempo: baseline
|
paternal involvement will be assessed with 5 questions
|
baseline
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 09.2021.489
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Problema di comportamento del bambino
-
MedDay Pharmaceuticals SAEurofins OptimedTerminatoVolontari sani | Compromissione epatica della categoria Child Pugh moderataFrancia, Ungheria
-
The Hospital for Sick ChildrenBill and Melinda Gates Foundation; Aga Khan UniversityAttivo, non reclutanteUnder Five Child Health Nutrizione e immunizzazionePakistan
-
RenJi HospitalCompletatoRapporto conta piastrinica/diametro milza | Classificazione Child-PughCina
-
Stanford UniversityNational Cancer Institute (NCI)TerminatoCarcinoma epatocellulare ricorrente | Child-Pugh Classe A | Child-Pugh Classe BStati Uniti, Giappone
-
Jouf UniversityCompletatoTerapia cognitivo comportamentale e problem solving | Disturbi dell'autismo e stress maternoEgitto, Arabia Saudita
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsCompletatoChild-Pugh Classe A | Carcinoma epatocellulare in stadio IIIA | Carcinoma epatocellulare in stadio IIIB | Carcinoma epatocellulare in stadio IIIC | Carcinoma epatocellulare in stadio IVA | Carcinoma epatocellulare in stadio IVB | Child-Pugh Classe BStati Uniti
-
Boehringer IngelheimNon più disponibileMalattie polmonari, interstiziali (nelle popolazioni pediatriche) | Malattia polmonare interstiziale infantile (chILD)
-
Centre Hospitalier Universitaire DijonCompletatoCarcinoma epatocellulare di Child-Pugh AFrancia
-
MindRank AI LtdNon ancora reclutamentoCompromissione Epatica (Lieve e Moderata, Classi A e B di Child-Pugh) | Insufficienza Epatica (ID MeSH: D048550)Cina
-
CatalYm GmbHReclutamentoCarcinoma epatocellulare di Child-Pugh A | Carcinoma epatocellulare non resecabile o metastatico | Fallimento del trattamento di prima linea che includeva un composto anti PD-(L)1 approvatoItalia, Germania